Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

Human papillomavirus (HPV), the most common sexually transmitted infection in the US and
worldwide, can cause cancers, anogenital warts (AGW), and recurrent respiratory …

Introduction: The objective of this study was to assess the incremental costs and benefits of
the 9-valent HPV vaccine (9vHPV) compared with the quadrivalent HPV vaccine (4vHPV) …

Abstract Background: The New Mexico HPV Pap Registry was established to measure the
impact of cervical cancer prevention strategies in the United States. Before widespread …

Background. We estimated the potential impact and cost-effectiveness of providing 3-doses
of nonavalent human papillomavirus (HPV) vaccine (9vHPV) to females aged 13–18 years …

Objective The aim of the study was to investigate the effects of 3 or less quadrivalent human
papillomavirus (HPV) vaccine doses on anogenital warts in both males and females in the …

Abstract Introduction In the United States, routine human papillomavirus (HPV) vaccination
is recommended for females and males at age 11 or 12 years; the series can be started at …

Human papillomavirus (HPV) vaccine uptake among 18–26 y old women varies by
geographic region in the US. However, little is known about regional variations in …

Background Australian guidelines for cervical cancer screening are being revised under the
“renewal program”. Physicians' willingness to accept these changes will play a pivotal role in …

During the past decade, numerous models have been developed to estimate the impact and
cost-effectiveness of human papillomavirus (HPV) vaccination in developed countries [1, 2] …